Paclitaxel Plus Oxaliplatin for Recurrent or Metastatic Cervical Cancer: A New York Cancer Consortium Study

OBJECTIVE: Survival in women with recurrent or metastatic cervical cancer remains poor. More effective and less toxic regimens are needed. Cisplatin is an effective radiosensitizer, but its single agent activity in recurrent cervical cancer, especially after prior cisplatin exposure, is disappointin...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Kuo, Dennis Yi-Shin, Blank, Stephanie V., Christo, Paul J., Kim, Mimi, Caputo, Thomas A., Pothuri, Bhavana, Hershman, Dawn, Goldman, Noah, Ivy, Percy S., Runowicz, Carolyn D., Muggia, Franco, Goldberg, Gary L., Einstein, Mark H.
Médium: Artigo
Jazyk:Inglês
Vydáno: 2009
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC2822050/
https://ncbi.nlm.nih.gov/pubmed/19931137
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ygyno.2009.10.082
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky